Pharmaceutical

Image

Asia-Pacific Dermatology Drugs Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Jan 2023
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Asia-Pacific Dermatology Drugs Market, By Drug Class (Corticosteroids, Retinoids, Monoclonal Antibodies, Antibiotics Agent, Antiviral Agents, Antifungal Drugs, Antihistamines Agents, Immunosuppressive Drugs, Others), Drug Type (Branded, Generics), Dermatological Diseases (Acne, Dermatitis, Psoriasis, Skin Cancer, Others), Prescription Mode (Prescription Based Drugs, Over-The-Counter Drugs), Route of Administration (Oral, Topical, Parenteral), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2030.

Asia-Pacific Dermatology Drugs Market

Asia-Pacific Dermatology Drugs Market Analysis and Size

The dermatology drugs industry has increased in the last few years due to the increasing expenditure for the skin care that accelerated the pace of expansion. Dermatology drug demand has shown great improvement to the previous year with increasing awareness for diagnostics and treatment of skin diseases. In addition, demand for dermatology drugs has risen in emerging countries with the increased spending on healthcare.  

Data Bridge Market Research analyses a growth rate in the dermatology drugs market in the forecast period 2023-2030. The expected CAGR of dermatology drugs market is tend to be around 11% in the mentioned forecast period. The market value is USD 5118.7 million in 2022, and it would grow up to USD 11,796.4 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Asia-Pacific Dermatology Drugs Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Dermatological Diseases (Acne, Dermatitis, Psoriasis, Skin Cancer, Others), Drug Class (Corticosteroids, Retinoids, Monoclonal Antibodies, Antibiotics Agent, Antiviral Agents, Antifungal Drugs, Antihistamines Agents, Immunosuppressive Drugs, Others), Drug Type (Branded, Generics), Prescription Mode (Prescription Based Drugs, Over-The-Counter Drugs), Route of Administration (Oral, Topical, Parenteral), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)

Countries Covered

China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC)

Market Players Covered

LUPIN (India), Novartis AG (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc. (U.S.), Sanofi (France), Amgen inc. (U.S.), Lilly (U.S.), AstraZeneca (U.K.), AbbVie Inc (U.S.), Johnson & Johnson Private Limited (U.S.), LEO Pharma A/S (Denmark), Merck & Co., Inc (U.S.), Bausch Health Companies Inc (Canada) and Bristol-Myers Squibb Company (U.S.)

Market Opportunities

  • Rising Incidence of Skin Diseases

Market Definition

Dermatological drugs, also termed dermatologic, are the type of products applied topically to the skin. Such drugs are widely used for the diagnosis of skin diseases and are often used to prevent some skin disorders. Although, dermatological are widely used to protect the skin for a regular skin care. Dermatology drugs are categorized into antifungal drugs, immunosuppressive drugs, corticosteroids, monoclonal antibodies, antibiotics agent, retinoids, antiviral agents, and antihistamines agents among others.

Asia-Pacific Dermatology Drugs Market Dynamics

Drivers

  • Increasing Aged Population

The geriatric population loses the ability to function properly with passing age, leading to several skin illnesses. Moreover, as the person ages, the body starts to experience numerous additional issues, which includes slower wound healing, high sensitivity to ultraviolet (UV) radiation, more susceptibility to infections, and reduced subcutaneous fat. The need for dermatological medications has increased because of the likelihood of many skin conditions.

  • Increasing Clinical Research

The market is anticipated to increase as more and more clinical studies are performed to evaluate the safety and efficacy of a variety of medicinal medications. For instance, in December 2021, the pharmaceutical company Amgen Inc. declared the favourable findings of a phase 3 placebo-controlled, double-blind clinical research. The main aim is to assess Otezla's effectiveness in managing moderate to severe psoriasis.

Opportunities

  • Rising Incidence of Skin Diseases

The increased frequency of skin cancer and other associated skin disorders or other skin issues such as vitiligo, acne, and dermatosis along with the increasing demand of effective drugs are the most primary factors boosting the growth for this market. Fungal infection and acne were more prevalent in the adolescent age group, resulting in about 17.4% and 30.4%, respectively. Around 84.5 million Americans, one in four, were hugely impacted by skin disease. Acne is the most common skin condition in the U.S., affecting more than 50 million Americans every year. Acne typically begins in puberty and affects several adolescents and young adults. As per the records of the World Psoriasis Day consortium, around 125 million people globally which means that 2 to 3 percent of the total population suffer from psoriasis,. Thus, this boosts the market growth.   

Restraints/Challenges

  • High Cost of Treatment

The increased expenditure related with these drugs hamper the market growth. Numerous market players make huge investments in the manufacturing of new drugs to increase the recovery process; which increases the cost.  Thus, this factor obstructs the market growth as the treatment options are not viable for all the economic groups.

  • Lack of Reimbursement Policies

A huge lack of reimbursement for several dermatology drugs is expected to limit the market growth. Both public and private payers do not recompense majority of the treatment services. The increased cost of such services vary greatly and there cannot be any standardization. Thus, this factor hampers the market growth.

This dermatology drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the dermatology drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Asia-Pacific Dermatology Drugs Market Scope

The dermatology drugs market is segmented on the basis of drug class, dermatological diseases, prescription mode, route of administration, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Dermatological Diseases

Prescription mode 

  • Prescription Based Drugs
  • Over Counter Drugs

Drug Class

  • Corticosteroids
  • Cortisone
  • Hydrocortisone
  • Prednisone
  • Astringents
  • Alum
  • Acacia
  • Sage
  • Anti-Inflammatory & Antipruritic Drugs
  • Ibuprofen
  • Naproxen
  • Aspirin
  • Anti-Infective/Antibacterial Drugs
  • Penicillins and β-lactamase inhibitors
  • Cephalosporins
  • Antifungal Drugs
  • Clotrimazole
  • Econazole

Route of Administration

  • Topical
  • Oral
  • Parenteral Administration

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Dermatology Drugs Market Regional Analysis/Insights

The dermatology drugs market is analyzed and market size insights and trends are provided by dermatological diseases, drug class, drug type, prescription mode, route of administration, and distribution channel as referenced above.

The major countries covered in the dermatology drugs market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).

Japan is dominating the market because of the growing focus on the dermatological health and growing awareness about good health and increasing spending on healthcare.

China is having the highest market share due to increasing spending on health care in the country as demand for branded drugs is increasing. Also, the increasing awareness for diagnostics and treatment of skin diseases combined with the growing prevalence of skin diseases in the country has increased the demand for dermatology drugs.  

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of asia-pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data. 

Competitive Landscape and Asia-Pacific Dermatology Drugs Market Share Analysis

The dermatology drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, asia-pacific presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to dermatology drugs market.

Key players operating in the dermatology drugs market include:

  • LUPIN (India)
  • Novartis AG (Switzerland)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Pfizer Inc. (U.S.)
  • Sanofi (France)
  • Amgen inc. (U.S.)
  • Lilly (U.S.)
  • AstraZeneca (U.K.)
  • AbbVie Inc (U.S.)
  • Johnson & Johnson Private Limited (U.S.)
  • LEO Pharma A/S (Denmark)
  • Merck & Co., Inc (U.S.)
  • Bausch Health Companies Inc (Canada)
  • Bristol-Myers Squibb Company (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Asia-Pacific Dermatology Drugs Market is projected to grow at a CAGR of 11.0% during the forecast period by 2030.
The future market value of the Asia-Pacific Dermatology Drugs Market is expected to reach USD 11,796.4 million by 2030.
The major players in the Asia-Pacific Dermatology Drugs Market are LUPIN (India), Novartis AG (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc. (U.S.), Sanofi (France), Amgen inc. (U.S.), Lilly (U.S.), AstraZeneca (U.K.), AbbVie Inc (U.S.), etc.
The countries covered in the Asia-Pacific Dermatology Drugs Market are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC)
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials